GENIX PHARMACEUTICALS CORP (GENX.CA) Stock Balance Sheet
TSX-V:GENX - TSX Venture Exchange - CA37232A1093 - Common Stock - Currency: CAD
| MRQ (2024-7-31) | 2023 (2023-10-31) | 2022 (2022-10-31) | 2021 (2021-10-31) | 2020 (2020-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 10.20K | N/A | 9.30K | 138.80K | 696.60K | |||
| Receivables | 4.90K | 1.40K | 16.50K | 4.90K | 7.90K | |||
| Inventories | 159.90K | 159.10K | 171.30K | 4.80K | N/A | |||
| Other Current Assets | 50.70K | 43.40K | 43.20K | 39.70K | 11.30K | |||
| Total Current Assets | 225.70K | 215.60K | 240.30K | 188.20K | 715.80K | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 0.00 | 3.70K | 32.40K | N/A | |||
| Intangibles | 7.10K | 7.90K | 4.01M | 4.55M | 4.63M | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 7.10K | 7.90K | 4.01M | 4.58M | 4.63M | |||
| TOTAL ASSETS | 232.80K | 223.50K | 4.25M | 4.77M | 5.35M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 739.30K | 511.50K | 177.60K | 15.20K | 15.20K | |||
| Current Portion Of LT Debt. | 579.20K | 580.20K | 641.00K | 685.60K | 197.50K | |||
| Accrued Expenses | 15.00K | 20.00K | 22.00K | 32.00K | N/A | |||
| Accounts Payable | 263.80K | 249.10K | 212.90K | 11.70K | 137.20K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 1.60M | 1.36M | 1.05M | 744.50K | 349.90K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 10.70K | 140.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 10.70K | 140.00K | |||
| TOTAL LIABILITIES | 1.60M | 1.36M | 1.05M | 755.20K | 489.90K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -11.07M | -10.84M | -6.50M | -5.69M | -4.84M | |||
| Common Shares | 9.70M | 9.70M | 9.70M | 9.70M | 9.70M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 59.22M | 59.22M | 59.22M | 59.22M | 59.22M | |||
| Tangible Book Value per Share | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 | |||
| Total Shareholders' Equity | -1.36M | -1.14M | 3.20M | 4.01M | 4.86M | |||
| TOTAL LIABILITIES AND EQUITY | 232.80K | 223.50K | 4.25M | 4.77M | 5.35M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.01 | 0.03 | |||
| Current Ratio | 0.14 | 0.16 | 0.23 | 0.25 | 2.05 | |||
| Return On Assets (ROA) | -1717.18% | -1966.71% | -25.26% | -34.65% | -13.44% | |||
| Return On Equity (ROE) | N/A | N/A | -33.57% | -41.17% | -14.80% | |||
All data in CAD , ROIC based on taxRate of 0.28